|
Re: Successful CANTOS Inflammation Trial Supports Rationale for Resverlogix' Ongoing BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Aug 29, 2017 04:14PM
|
|
Re: Wonderful
|
4
|
Resverlogix Corp.
|
Aug 28, 2017 08:48PM
|
|
Re: Wonderful
|
2
|
Resverlogix Corp.
|
Aug 28, 2017 11:58AM
|
|
Re: What credibility?
|
3
|
Resverlogix Corp.
|
Aug 27, 2017 04:37PM
|
|
Re: While we wait, outside items that may be of interest
|
2
|
Resverlogix Corp.
|
Aug 27, 2017 11:11AM
|
|
Re: At least we closed up.....
|
1
|
Resverlogix Corp.
|
Aug 26, 2017 10:30AM
|
|
Re: Entertainment During Wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2017 03:24PM
|
|
Re: Kick the can
|
2
|
Resverlogix Corp.
|
Aug 24, 2017 10:28PM
|
|
Re: Kick the can
|
1
|
Resverlogix Corp.
|
Aug 24, 2017 10:00PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 23, 2017 05:00PM
|
|
Re: 96 hours
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 07:55PM
|
|
Re: 96 hours
|
|
Resverlogix Corp.
|
Aug 22, 2017 12:18PM
|
|
Re: On the Stockhouse Board this morning
|
1
|
Resverlogix Corp.
|
Aug 21, 2017 12:50PM
|
|
Re: Courtesy
|
2
|
Resverlogix Corp.
|
Aug 19, 2017 01:17PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
4
|
Zenith Epigenetics
|
Aug 17, 2017 07:13PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
3
|
Zenith Epigenetics
|
Aug 17, 2017 12:09PM
|
|
Re: A clinical future for RVX-2135 or just a pre-clinical tool
|
6
|
Zenith Epigenetics
|
Aug 16, 2017 03:33PM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
1
|
Resverlogix Corp.
|
Aug 16, 2017 10:58AM
|
|
Re: Resverlogix (RVX) Reports Fiscal Year 2017 Results
|
5
|
Resverlogix Corp.
|
Aug 15, 2017 06:26PM
|
|
Re: Q3 Events updated
|
2
|
Resverlogix Corp.
|
Aug 11, 2017 03:09PM
|
